Navigation Links
XTL Biopharmaceuticals Implements Restructuring Plan
Date:12/8/2008

VALLEY COTTAGE, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced today that it is restructuring its operations following the failure of the Bicifadine Phase 2b clinical trial. The company is terminating the employment of 9 employees, representing 75% of its workforce. The remaining employees will be responsible for seeking potential assets or a company to merge into XTL, or for assisting in the liquidation and/or disposition of XTL's assets.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future business prospects, may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. It is possible that we will not be able to find a buyer for the assets or a merger partner. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.xtlbio.com . The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.


'/>"/>
SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
5. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
6. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
9. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
10. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
11. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ease is available in German . , Whether it,...: RFID tags (Radio Frequency Identification) are i...They make it possible to label objects or goods an...The appropriate scanner can read and process the d...fixed to goods under production conditions of up t...
(Date:11/24/2009)... The New York investment bank KTA Ca...) has agreed an AU$6.7 mil convertible note privat...e private placement was arranged by KTA Capital as..., New York (PRWEB) Novembe...bank KTA Capital, LLC ("KTA Capital") ha...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced that it has received...in the company,s common stock will be,suspended as...led with the,Securities and Exchange Commission, w...g on Nasdaq, unless the company files an appeal to...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced the approval of all ...Court for the District of Delaware,(the "Bankruptc...tion for,relief under Chapter 11 of the United Sta..., The orders issued by the Bankruptcy Court ...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...stic Systems Installs CTLM(R) in Tianjin, China, ... Systems, Inc., (OTC Bulletin Board: IMDS) a pione... has installed a CT Laser Mammography,(CTLM(R)) sy...stitute and,Hospital, the largest breast disease c...i-bin/prnh/20040412/IMDSLOGO ) Research at the C...
.... 5 /PRNewswire-FirstCall/ - Biomira Inc. (Nasdaq:...on of three-year survival results,from a randomize...in,non-small cell lung cancer (NSCLC). The results...ve care (BSC) may provide survival benefits to,pat...ither responded or had,stable disease after initia...
...CISCO, Calif., Sept. 5 Hyperion,Therapeutics, a b...t and,commercialization of gastrointestinal and he... Disorders (UCD) and Hepatic Encephalopathy (HE),t...eading the round was,Sofinnova Ventures, with equa..., all of Menlo Park, CA. WRF Capital of Seattle, W...
Other Biology Technology:Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 2Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System 3Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 2Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 3Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer 4Hyperion Therapeutics Secures $40 Million In Series B Round 2
(Date:11/26/2009)...have at last worked out a way of using recordings ... populations. This is the first time sound recordi...nto accurate estimates of bird species, population...ish Ecological Society,s Journal of Applied Ecolo... to a major advance in our ability to monitor whal...
(Date:11/25/2009)...alif.Scientists at the California Institute of Tec...mitive emotion-like behavior in the fruit fly, Dr...may be relevant to the relationship between the ne...ractivity disorder (ADHD), are described in the De...sophila brain contains only about 20,000 neurons ...
(Date:11/25/2009)..., NOVEMBER 25, 2009 Soil is the linchpin of the e...sphere meet. Despite that, many students see soil ...g more. Soil science educators are challenged with...nize the critical importance of soil in the enviro...e and earth science teachers at University of Nebr...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2Celsis IVT Granted U S Patent for LiverPool 28TM 29 Hepatocytes 14543 1Celsis IVT Granted U S Patent for LiverPool 28TM 29 Hepatocytes 14543 2B Braun and Amerinet Sign to Expand Infusion Therapy Offerings 5606 1B Braun and Amerinet Sign to Expand Infusion Therapy Offerings 5606 2B Braun and Amerinet Sign to Expand Infusion Therapy Offerings 5606 3Code Blue Recovery Drink Features Sustamine 28TM 29 from Kyowa Hakko 5601 1Code Blue Recovery Drink Features Sustamine 28TM 29 from Kyowa Hakko 5601 2
...ception likely to be available in the near future,...NCET highlight how such contraception is reversibl...contraceptive methods (condoms, withdrawal, and va...e they are either not sufficiently reliable or not...suppression by hormone treatment in women, sperm p...
...tention in infancy has revealed that, at just four...formation in at least three different ways, accord... elements are together (proximity). These new find...pable of organising their visual world than psycho...s implications for understanding certain developme...
...y scientist Chien Ho and his colleagues have devel... imaging (MRI) to track immune cells as they infil...organ rejection. This pre-clinical advance, descri... National Academy of Sciences (PNAS), ultimately c...nt rejection in patients. , "We have reported for ...
Other Biology News:Hormonal male contraception reversible after few months for all men 2Infants can organise visual information at just four months 2Infants can organise visual information at just four months 3Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level 2Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level 3
Rat Plasmin from Pel-Freez Biologicals
Goat Anti-Human FADD Polyclonal Antibody, Unconjugated from R&D Systems
Porcine Galanin , 3-[125I]iodotyrosyl26 Conjugated/Tagged from GE Healthcare, formerly Amersham Biosciences
...ts the new standard for value in today's cost-cons...ologies and providing tailored solutions for all l...heric Pressure Ionization (API) interface and the ...selectivity and sensitivity for pharmaceutical, cl...
Biology Products: